Meihao Medical Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	101.69	74.68	73.51	127.41	105.32
Revenue Growth (YoY)	36.17%	1.59%	-42.30%	20.98%	24.55%
Cost of Revenue	61.93	47.7	40.86	49.16	38.39
Gross Profit	39.76	26.98	32.66	78.25	66.93
Selling, General & Admin	60.42	59.53	43.6	35.71	22.6
Operating Expenses	60.41	59.54	43.6	35.69	22.29
Operating Income	-20.65	-32.56	-10.95	42.56	44.64
Interest Expense	-0.53	-1.62	-1.63	-1.89	-2.47
Interest & Investment Income	2.95	3.7	4.97	1.65	1.21
Currency Exchange Gain (Loss)	-1.44	0.11	0.06	-	-
Other Non Operating Income (Expenses)	0.34	0.22	0.07	-0.84	0.03
EBT Excluding Unusual Items	-19.34	-30.15	-7.48	41.49	43.41
Gain (Loss) on Sale of Investments	0.7	-	-	-	-
Gain (Loss) on Sale of Assets	-0.42	-	-	-	-
Other Unusual Items	2.92	0	0.32	-1.28	0.26
Pretax Income	-16.14	-30.15	-7.16	40.2	43.67
Income Tax Expense	-1.99	2.48	6.45	11.63	11.49
Earnings From Continuing Operations	-14.15	-32.62	-13.61	28.57	32.18
Minority Interest in Earnings	-0.19	0.2	0.01	-0.11	-0.11
Net Income	-14.34	-32.42	-13.59	28.46	32.07
Net Income to Common	-14.34	-32.42	-13.59	28.46	32.07
Net Income Growth	-	-	-	-11.27%	115.19%
Shares Outstanding (Basic)	582	582	600	457	450
Shares Outstanding (Diluted)	582	582	600	457	450
Shares Change (YoY)	-0.03%	-3.01%	31.18%	1.64%	-
EPS (Basic)	-0.02	-0.06	-0.02	0.06	0.07
EPS (Diluted)	-0.02	-0.06	-0.02	0.06	0.07
EPS Growth	-	-	-	-12.70%	-
Free Cash Flow	-	-16.05	0.05	24.17	28.6
Free Cash Flow Per Share	-	-0.03	-	0.05	0.06
Dividend Per Share	-	-	0.009	-	-
Gross Margin	39.10%	36.12%	44.42%	61.41%	63.55%
Operating Margin	-20.31%	-43.60%	-14.89%	33.41%	42.38%
Profit Margin	-14.10%	-43.42%	-18.49%	22.34%	30.45%
Free Cash Flow Margin	-	-21.49%	0.07%	18.97%	27.16%
EBITDA	-14.16	-26.07	-3.66	48.69	49.13
EBITDA Margin	-13.93%	-34.91%	-4.98%	38.21%	46.65%
D&A For EBITDA	6.49	6.49	7.29	6.13	4.49
EBIT	-20.65	-32.56	-10.95	42.56	44.64
EBIT Margin	-20.31%	-43.60%	-14.89%	33.41%	42.38%
Effective Tax Rate	-	-	-	28.93%	26.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.